Key facts
- Harwood Capital has increased its stake in M&C Saatchi.
- Harwood Capital now holds over 8% of M&C Saatchi shares.
- Harwood Capital is pushing M&C Saatchi to sell off its divisions.
- Harwood Capital is advocating for a potential breakup of M&C Saatchi.
- Ananym Capital Management has acquired a stake in Bio-Techne.
- Ananym Capital is urging Bio-Techne's board to initiate a strategic review.
- The strategic review at Bio-Techne may include a potential sale of the company.
Activist investor Harwood Capital has significantly increased its stake in the advertising firm M&C Saatchi, now holding over 8% of the company's shares. This move signals Harwood Capital's intention to push for a breakup of M&C Saatchi, with the investor advocating for the sale of the company's various divisions. The specific divisions targeted for divestment are not detailed, but the overall strategy points towards a potential dismantling of the firm.
In a parallel development, activist investor Ananym Capital Management has acquired a stake in Bio-Techne, a company in the biotechnology sector. Ananym Capital is actively engaging with Bio-Techne's board, urging them to initiate a comprehensive strategic review. This review process could potentially culminate in the sale of the company, indicating a similar push for significant corporate action.